Cargando…
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review
Apatinib, a novel small molecule tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor-2, was approved for metastatic gastric adenocarcinoma in China in Oct 2014. This is the first report on its use for advanced colorectal cancer as a kind of third-line therapy to date....
Autores principales: | Bi, Minghong, Yang, Jingru, Wang, Yaping, Zhang, Haoran, Gao, Zhenyuan, Zhou, Hairong, Shi, Mohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823067/ https://www.ncbi.nlm.nih.gov/pubmed/29497319 http://dx.doi.org/10.2147/OTT.S148412 |
Ejemplares similares
-
Apatinib successfully administered in malignant tumour patients with severe hypotension: a case series, literature review, and considerations for treatment
por: Chen, Haiming, et al.
Publicado: (2023) -
Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma
por: Bi, Minghong, et al.
Publicado: (2019) -
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017) -
Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019) -
Apatinib mesylate tablet in the treatment of advanced malignant melanoma
por: Yang, Lingge, et al.
Publicado: (2018)